CD8A and cancer: The aims of this study were to determine if SPARC and FOXP3 expression levels are associated with CRC stage, disease outcome and long-term cancer-specific survival in stage II and III CRC and to compared the prognostic value of these two markers against the known prognostic CRC markers CD8 and CD45RO.